Santhera Pharmaceuticals Stock Forward View - Relative Strength Index
| SANN Stock | CHF 15.72 0.26 1.68% |
This page provides Relative Strength Index reference data for Santhera Pharmaceuticals Holding, calculated from historical daily prices. The model output shown here is derived from Santhera Pharmaceuticals's historical price series and is provided for informational purposes. Projected values and accuracy measures are included for reference.
The Relative Strength Index reference information for Santhera Pharmaceuticals is based on available price data and is intended for informational purposes. Relative Strength Index Analysis Today
Santhera Pharmaceuticals Holding has current Relative Strength Index of 51.42.| Previous Relative Strength Index | Relative Strength Index | Trend |
| 45.04 | 51.42 |
| Volatility | Backtest | Information Ratio |
Santhera Pharmaceuticals Trading Date Momentum
| On March 26 2026 Santhera Pharmaceuticals Holding was traded for 15.72 at the closing time. The highest price during the trading period was 15.72 and the lowest recorded bid was listed for 14.80 . The volume for the day was. This history from March 26, 2026 did not result in any price rise and fall. The trading price change to the current price is -2.04% . |
| Compare Santhera Pharmaceuticals to competition |
Other Forecasting Options for Santhera Pharmaceuticals
The autocorrelation structure of Santhera Pharmaceuticals' daily returns reveals whether Santhera exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in Santhera Stock price data. Stochastic oscillator analysis compares Santhera Pharmaceuticals' closing price to its range over a given period.Santhera Pharmaceuticals Related Equities
These firms work in a similar space as Santhera Pharmaceuticals within the Health Care space and serve as useful points for comparison. Return on equity across these peers shows how well each firm turns capital into profit. When Santhera Pharmaceuticals breaks from its peer group on a key metric, it often signals a firm-level change worth exploring. This type of review is most useful when done often to track how positions shift over time.
| Risk & Return | Correlation |
Santhera Pharmaceuticals Market Strength Events
Market strength indicators applied to Santhera Pharmaceuticals stock help assess momentum and resilience across environments. These indicators support informed market timing decisions when analyzing Santhera Pharmaceuticals. For Santhera Pharmaceuticals Holding, market strength indicators complement fundamental analysis with timing context.
Santhera Pharmaceuticals Risk Indicators
Risk indicator analysis for Santhera Pharmaceuticals is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in Santhera Pharmaceuticals' investment and either accepting or mitigating it. Understanding the risk profile of Santhera Pharmaceuticals' allows investors to make more informed decisions about position sizing.
| Mean Deviation | 2.84 | |||
| Semi Deviation | 2.96 | |||
| Standard Deviation | 3.64 | |||
| Variance | 13.28 | |||
| Downside Variance | 10.67 | |||
| Semi Variance | 8.74 | |||
| Expected Short fall | -3.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Santhera Pharmaceuticals
A coverage review of Santhera Pharmaceuticals Holding shows when the security is attracting above-average attention from contributors and market observers. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Santhera Pharmaceuticals Short Properties
Short sentiment tied to Santhera Pharmaceuticals Holding matters because heavier bearish pressure can change how quickly future price expectations become unstable. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 11.4 M | |
| Cash And Short Term Investments | 40.9 M |
Additional Tools for Santhera Stock Analysis
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |